A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index


About Titan:

Titan Pharmaceuticals, Inc. (ASE: TTP) is a biopharmaceutical company focused on the development and commercialization of novel treatments for central nervous system disorders, cancer and cardiovascular disease. Titanís products in development utilize novel technologies that have the potential to significantly improve the treatment of these diseases. Titan also establishes partnerships with government institutions and other leading pharmaceutical development companies. Titan's product development pipeline includes six products in clinical testing:

Phase IIPivanexRefractory Chronic Lymphocytic Leukemia
Phase IIDITPACongestive Heart Failure
Phase I/IIProbuphineopiate addition
Phase IISpheramineAdvanced Parkinson's
Phase IIIIloperidone Schizophrenia
 Gallium Maltolate Bone Disease


NIH Trials for Titan


More on Titan:

Home Page

Key Statistics for Titan

Basic Chart for Titan

Analyst Opinion

Analysts Estimates


Biotech100 Index
What are the Requirements to be listed in the Biotech100 Index?
See the Biotech100 List

Sponsored Links

Clinical Trials
What is a Clinical Trial?
Phase I ,-- Phase II, -- PhaseIII
What is Randomized Control?
 What is a Double Blind Experiment?
What is the role of the FDA?


Key Biotech Terms


Biotech Resources


Investing in Stocks
Small Cap Stocks
Stocks and Bonds
Biotech100 Index

Careers and Employment
Biotechnology and Pharmaceutical
What are the Fastest Growing Careers?




Copyright © 2005 BIOTECH100.COM. All rights reserved.